St. Francis Cancer Center | St. Francis Cancer Center | BMS CA209-812
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1864
clinical-trial-template-default,single,single-clinical-trial,postid-1864,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Clinical Trials

BMS CA209-812

Randomized, Open-label, Phase 3 Trial of Nivolumab plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Participants with Relapsed Refractory or Ineligible for Autologous Stem Cell Transplant (ASCT) Advanced Stage Classical Hodgkin Lymphoma. >Read More

« Available Clinical Trials